H Clinical Announces Majority Investment from Emerald Square Ventures

Investment supports expansion of in-country clinical research staffing, patient recruitment and hybrid delivery capacity for sponsors and CROs across Latin America.

ST. PETERSBURG, Fla., Sept. 16, 2026 /PRNewswire/ -- H Clinical today announced a partnership with Emerald Square Ventures (ESV), which made a majority investment in H Clinical, Inc. Mitchell Parrish continues as Chief Executive Officer.

"What we have spent six years building is difficult to build and impossible to shortcut — people in the communities where trials run, their relationships with sites, and the infrastructure behind them," said Mitchell Parrish, CEO of H Clinical. "This investment puts more of it in front of clients."

H Clinical has also added two executives to its leadership team. Ben Joers joins as Chief Financial Officer, leading financial strategy, planning and infrastructure. Eddie Hannush joins as Chief Commercial Officer, leading commercial strategy and the growth of client partnerships and service offerings.

"We work with sponsors, CROs, and sites in whatever combination a study needs," said Eddie Hannush, Chief Commercial Officer. "When staffing, recruitment, home visits and logistics run off one local platform, the study moves faster and the patient has a better experience."

The investment supports the services clients are asking H Clinical to expand, and the in-country teams behind them:

• Site solutions and project staffing. Clinical research coordinators, nurses and study personnel sourced, trained and managed by H Clinical for sites region-wide — on site, remote or hybrid.
• Community-based patient recruitment. Patient engagement teams working through referring physicians, health centers, patient associations and community events.
• In-home and hybrid trial support. Study visits in patients' homes, with sample collection, shipments and in-country regulatory work.
• Procurement and logistics. Regional depots, local sourcing, equipment rental and courier networks.

Please reach out to discuss trial support opportunities.

About H Clinical

H Clinical is the leading clinical research operating platform in Latin America, working through its own in-country teams across 22 countries. It supports sponsors, contract research organizations and research sites with clinical research staffing, in-home trial support, community-based patient recruitment, and procurement logistics. H Clinical empowers sponsors to reach patients that usual channels miss. The company operates the largest in-home trial, mobile site, logistics and depot network in the region.

About Emerald Square Ventures

Emerald Square Ventures is an operator-led investment platform that acquires and operates clinical research and life sciences businesses.

Media Contact

Media Relations

[email protected] | 727-201-1153

View original content to download multimedia:https://www.prnewswire.com/news-releases/h-clinical-announces-majority-investment-from-emerald-square-ventures-302880623.html

SOURCE H Clinical